无法解释的巨型肺栓塞在壮病患者:一个病例报告
Usamah Al-Anbagi1, Shybin Usman1, Abdulrahman Saad2
1Medicine Department Hazm Mebaireek General Hospital, Hamad Medical Corporation (HMC) Doha Qatar.
Clinical case reports
|May 13, 2024
概括
巨可能会增加静脉血栓塞栓症 (VTE) 的风险,即使有正常的血栓友测试结果. 需要进一步的研究来了解这种联系,并改善患者管理.
科学领域:
- 内分泌学 在内分泌学.
- 血液学 血液学 血液学
背景情况:
- 由生长激素过量引起的巨,与高血压和糖尿病等并发症有关.
- 之前的研究表明,在壮症中存在静血因子异常,但VTE的关联不清楚.
研究的目的:
- 突出壮症作为静脉血栓塞栓症 (VTE) 的潜在危险因素.
- 为了调查壮症和VTE之间的关系.
- 促使对潜在机制进行进一步研究.
主要方法:
- 一个36岁的男性患有巨症和双侧肺栓塞的病例介绍.
- 评估包括彻底的血栓友爱检查.
主要成果:
- 患者出现了肺栓塞的症状.
- 血栓过敏症工作给出了不起眼的结果.
- 在这种情况下,巨症被确定为VTE的潜在风险因素.
结论:
- 壮体应该被认为是VTE的潜在风险因素.
- 进一步的研究是必要的,以了解连接壮病和血栓友的机制.
- 需要对壮病患者进行更好的风险评估和管理策略.
相关概念视频
Pneumothorax-II
141
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
141
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Acute Respiratory Failure-III
183
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
183
Respiratory System Abnormal Finding I: Inspection and Percussion
261
Respiratory system abnormalities are a significant concern in healthcare due to their potential to indicate underlying severe conditions like Chronic Obstructive Pulmonary Disease (COPD), asthma, and pneumonia. These abnormalities can often be detected through physical examination methods like inspection and percussion.
Inspection Findings
During an inspection, several findings may suggest the presence of respiratory distress or disease. Pursed-lip breathing, where exhalation is slowed by...
Inspection Findings
During an inspection, several findings may suggest the presence of respiratory distress or disease. Pursed-lip breathing, where exhalation is slowed by...
261
Acute Respiratory Failure-IV
153
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
153
Flail Chest-II
165
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
165


